Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 306651000001113 | Caplacizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 306661000001111 | Caplacizumab (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Caplacizumab | Is a | von Willebrand factor antibody | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Caplacizumab 10mg powder and solvent for solution for injection vials | Has specific active ingredient | False | Caplacizumab | Inferred relationship | Existential restriction modifier | |
| Cablivi 10mg powder and solvent for solution for injection vials (Sanofi Genzyme) | Has specific active ingredient | False | Caplacizumab | Inferred relationship | Existential restriction modifier | |
| Cablivi 10mg powder and solvent for solution for injection vials (Sanofi Genzyme) 1 vial | Has specific active ingredient | False | Caplacizumab | Inferred relationship | Existential restriction modifier | |
| Caplacizumab 10mg powder and solvent for solution for injection vials 1 vial | Has specific active ingredient | False | Caplacizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR